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Carnosic acid is a major polyphenol of rosemary and possesses potent anti-oxidant effects. The present
study was designed to evaluate in vitro and in vivo effects of carnosic acid on bone formation and
maintenance. Carnosic acid attenuated H2O2 levels in osteoblastic MC3T3-E1 cells. This compound also
inhibited the indices of osteoblast differentiation, such as alkaline phosphatase activity and calcium
deposition in osteoblastic MC3T3-E1 cells at concentrations of 3–10mM. Furthermore, it decreased the
formation of multinucleated osteoclasts in co-cultures of mouse spleen cells with ST2 cells. In addition,
we identiﬁed a molecular pathway of osteoclast differentiation mediated by carnosic acid, which led to
inhibition of the expression of receptor activator of nuclear factor-kB ligand in ST2 cells. Interestingly,
intraperitoneal injection of carnosic acid at 10mg/kg body weight did not signiﬁcantly affect trabecular
bone loss in the femurs of ovariectomizedmice. Our ﬁndings indicate that carnosic acidmaybe used as an
effective remedy in the treatment of the symptoms of osteoporosis.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Bone formation involves a complex series of events that involve
the proliferation and differentiation of osteoprogenitor cells,
resulting in the formation of a mineralized extracellular matrix.
The deposition of calcium and sequential expression of type I
collagen, alkaline phosphatase (ALP), and osteocalcin are known as
markers of osteoblastic differentiation. Preosteoblastic cells from
mouse calvariae (MC3T3-E1 cells) are well-known as a model
system that has been developed to study the proliferation and
differentiation of bone-forming cells in vitro and the molecular
biology of the mineralization process [1,2]. Osteoclasts are
multinucleated giant cells with the ability to resorb mineralized
tissues that are formed from hematopoietic cells of the monocyte/
macrophage lineage [3]. The development of osteoclasts in cell
cultures is strictly dependent on the support provided by
osteoblasts and/or stromal cells [3]. The formation and activation
of osteoclasts are controlled by the combined actions of receptor).
.V. This is an open access article unactivator of nuclear factor-kB ligand (RANKL) [4,5] and macro-
phage colony-stimulating factor (M-CSF) [6]. In the present study,
we used a co-culture of mouse spleen cells with ST2 cells. ST2 cells
derived from mouse bone marrow stromal cells were used as
feeder cells that expressed RANKL and M-CSF in response to
activated vitamin D3 [7–9].
In bone tissues, both the formation and maintenance of bone
are controlled by bone-forming osteoblasts and bone-resorbing
osteoclasts, and an imbalance between these two cell types leads
to bone metabolic diseases such as osteoporosis and osteopetrosis
[10]. We have screened natural polyphenols to identify factors that
may cause, prevent, or treat bone metabolic diseases such as
osteoporosis and osteopetrosis. Consequently, we reported that
curcumin [11], oleuropein [2], hydroxytyrosol [2], and apigenin
[12] attenuated bone loss in ovariectomized (OVX) mice.
Carnosic acid, a member of the polyphenol class (Fig. 1), is
distributed in rosemary and sage. In addition to its anti-oxidant
activity [13], carnosic acid possesses anti-inﬂammatory [14,15],
anti-bacterial [16], anti-cancer [17] properties and provides
protection to neurons [18]. Carnosic acid is also known to act
through activation of the Keap1/Nrf2 pathway [18,19], which is the
major regulator of cytoprotective responses to oxidative andder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Structure of carnosic acid.
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the effects of carnosic acid on bone metabolism with regard to
osteoblast and osteoclast functions. The present study was
designed to evaluate the in vivo and in vitro effects of carnosic
acid on the formation and maintenance of bone using cultured
mouse cells.We also investigated the preventive effects of carnosic
acid on bone loss in adult mice with ovariectomy-induced
osteoporosis.
2. Materials and methods
2.1. Materials
Carnosic acid was purchased from Enzo Life Science (Plymouth,
PA, USA) and this compound was isolated from Rosmarinus
ofﬁcinalis (purity; 98.2%).
2.2. Osteoblastic cell cultures
Preosteoblastic MC3T3-E1 cells were obtained from RIKEN Cell
Bank (Tsukuba, Japan). Cells were maintained in a 55-cm2 dish in
Alpha-modiﬁed minimum essential medium (a-MEM; Life
Technologies, Inc., Grand Island, NY, USA), supplemented with
10% fetal bovine serum (JRH Bioscience, Lenexa, KA, USA),
50 units/mL penicillin and 50mg/mL streptomycin, in a humidi-
ﬁed atmosphere of 5% CO2 in air at 37 C. After reaching 70%
conﬂuence, cells were detached by treatment with 0.05% trypsin,
replated in either 55-cm2 dishes or 12-well plates (area of each
well, 3.8 cm2) at a density of 1104 cells/cm2, and grown in
a-MEM supplemented with 10% fetal bovine serum, 50units/mL
penicillin, 50mg/mL streptomycin, 5mM b-glycerophosphate
(b-GP), and 50mg/mL ascorbic acid. Fresh medium and carnosic
acid were supplied to cells at 2-day intervals. MC3T3-E1 cells
formed nodules, and mineralization of nodules was observed
after cultivation for 2–3 weeks.
2.3. Measurement of intracellular reactive oxygen species
Intracellular reactive oxygen species were measured using the
oxidant-sensitive probe 20, 70-dichloroﬂuorescin diacetate (DCFH-
DA). Cells (2105 cells/dish) in 3.5-cm dishes were cultured for
48h followed by a 24h-treatment with carnosic acid. Thereafter,
the cells were incubated with 50mM DCFH-DA for 30min with
subsequent incubation with 500mM H2O2 for 30min and washed
with Hank’s balanced salt solution. Fluorescence emission was
detected by confocal laser scanning microscopy at excitation and
emission wavelengths of 488nm and 490–555nm, respectively.
Images were analyzed using a confocal scanning system (LSM700;
Carl Zeiss, Tokyo, Japan).2.4. Measurement of ALP activity
MC3T3-E1 cells were sub-cultured in 12-well plates in a-MEM
containing 10% fetal bovine serum, 5mM b-GP, and 50mg/mL
ascorbic acid. After the cells had reached conﬂuence (day 3),
carnosic acid was added to cultures at various concentrations for 7
days. Cells were washed with 10mM Tris–HCl at pH 7.2 and
sonicated in 1mL of 50mM Tris–HCl (pH 7.2) containing 0.1%
Triton X-100 and 2mMMgCl2 for 15 s with a sonicator (Ultrasonic
Disruptor UD-201; Tomy Co., Tokyo, Japan). ALP activity was
determined using an established technique with p-nitrophenyl
phosphate as the substrate [21]. Protein concentrations were
determined using BCA protein assay reagent (Pierce Chemical Co.,
Rockford, IL, USA) with bovine serum albumin as a standard.
2.5. Quantitation of calcium deposition
MC3T3-E1 cells were sub-cultured in a-MEM containing 10%
fetal bovine serum, 5mM b-GP, and 50mg/mL ascorbic acid. After
the cells had reached conﬂuence (day 3), carnosic acid was added
at various concentrations to the culture medium and cells were
sub-cultured for 9 days. The amount of calcium, deposited as
hydroxyapatite in the cell layer, was measured as follows: layers of
cells in 12-well plates were washed with PBS and incubated
overnight with 1mL of 2NHCl with gentle shaking. Ca2+ ions in the
samples were quantitated by the o-cresolphthalein complexone
methodwith a CalciumC kit (Wako Pure Chemical Industries). This
kit is speciﬁc for Ca2+ ions and has a detection limit of 1mg/mL. The
solution of Ca2+ ions (20mg/dL) provided in the kit was used as the
standard solution.
2.6. Formation of osteoclastic cells
Multinucleated osteoclastic cells were formed from spleen cells
by co-culture with ST2 cells (RIKEN Cell Bank, Tsukuba, Japan) that
had been stimulated by 107M 1a, 25-dihydroxy-vitamin D3 [1a,
25(OH)2 vitamin D3] (Wako Pure Chemical Industries, Ltd., Osaka,
Japan). ST2 cells (2104 cells/well) in 48-well plates (area of each
well, 0.75 cm2) were pre-cultured with 100nM 1a, 25(OH)2
vitamin D3 for 1 day to be expressed RANKL. Spleen cells were
collected from the splenic tissues of 6-week-old male ddY mice
(Sankyo Labo Service, Tokyo, Japan). Erythrocytes contaminating
the spleen cell fraction were eliminated by adding 0.83%
ammonium chloride in 10mM Tris–HCl (pH 7.4) to the cell pellet.
Mouse spleen cells (1105 cells/well) were spread on ST2 cell
layers in 48-well plates and cultured for 7 days. Cultures were
maintained at 37 C in a humidiﬁed atmosphere of 5% CO2 in air.
Fresh medium, 100nM 1a, 25(OH)2 vitamin D3 and carnosic acid
were supplied at 2-day intervals. The Institutional Animal Care and
Use Committee of Toin University of Yokohama approved all
animal protocols and procedures.
Multinucleated osteoclastic cells formed were ﬁxed in 3.7%
formaldehyde for 5min and then in a mixture of ethanol and
acetone (1:1; v:v) for 1min. These cells were then stained for
tartrate resistant acid phosphatase (TRAP) activity [3]. TRAP-
positive multinucleated cells (ﬁve or more nuclei) were counted
under a microscope (IX70; Olympus, Tokyo, Japan).
2.7. Real-time polymerase-chain-reaction (PCR)
The mRNA expression of RANKL and M-CSF in ST2 cells treated
with 100nM 1a, 25(OH)2 vitamin D3 was examined by real-time
PCR. The RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan) was used to
extract RNA from cells that had been exposed to carnosic acid for
2 days. Total RNA (1mg) was reverse transcribed using the
Transcriptor First Strand cDNA Synthesis Kit (Roche, Tokyo, Japan)
[(Fig._2)TD$FIG]
Fig. 2. Effect of carnosic acid on intracellular reactive oxygen species concentra-
tions. Cells were pre-treated with or without carnosic acid (1–10mM) for 48h
followed by the incubationwith 500mMH2O2. Intracellular reactive oxygen species
concentrationswere assessed as described in the Section 2. Data aremeans S.E. of
three to four separate experiments. **P<0.01 vs. control cells (vehicle).
[(Fig._3)TD$FIG]
Fig. 3. Effects of carnosic acid on ALP activity and mineralization of osteoblasts.
MC3T3-E1 cells were cultured in 12-well plates (8104 cells/well) with a-MEM
containing 10% fetal bovine serum, 5mM b-glycerophosphate, and 50mg/mL
ascorbic acid. After the cells reached conﬂuence (day 3), carnosic acid was added at
various concentrations (1–10mM) to the culture medium. Fresh medium with test
compound was supplied at 3-day intervals. A: ALP activity was measured at day 10
as described in the method. B: Deposition of Ca2+ ions was measured at day 12.
Quantitative analysis of Ca2+ ions was performed as described in the Section 2. All
values represent the mean S.D. of the results from three wells. Data are
representative of results from four separate experiments. *, P<0.05 vs. vehicle and
**, P<0.01 vs. vehicle.
H. Hagiwara et al. / PharmaNutrition 3 (2015) 1–6 3with random primers in a 20-mL reactionmixture according to the
manufacturer’s protocol. Quantitative polymerase chain reaction
analysiswas performedwith LightCycler 480 System II (Roche) and
LightCycler 480 SYBR Green I Master (Roche). PCR (95 C for 10 s,
55 C for 10 s, and 72 C for 10 s, for 45 cycles) was performed using
speciﬁc primers (sense primer, 50-TGTACTTTCGAGCGCAGATG-30,
and antisense primer, 50-CCCACAATGTGTTGCAGTTC-30) for mouse
RANKL, (sense primer, 50-TTGCCAAGGAGGTGTCAGAA-30, and
antisense primer, 50-TATTGGAGAGTTCCTGGAGC-30) for mouse
M-CSF, and (sense primer, 50-ACTTTGTCAAGCTCATTT-30, and
antisense primer, 50-TGCAGCGAACTTTATTG-30) for mouse glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH was used
as an internal standard for normalization of each sample.
2.8. Analysis of bone mineral density of OVX mice treated with
carnosic acid
BALB/c femalemice (6-weeks old) were purchased fromSankyo
Labo Service and were housed individually at 24 C with a 12-h
light-dark cycle. The mice underwent a sham-operation (n =5) or
were surgically ovariectomized (OVX; n =10) under anesthesia
with Nembutal1 injection (Dainippon Sumitomo Pharma, Tokyo,
Japan). The mice were assigned to three groups (n =5 for each): (1)
untreated mice (Sham: sham-operated controls); (2) untreated
mice (OVX controls); and (3) OVX mice administered intraperito-
neally with carnosic acid (OVX+CA; 10mg/kg body weight) at 2-
day intervals. Carnosic acidwas dissolved in saline before injection.
The volume ingested was 50mL. After the 28-day experimental
period, the left and right femurs were surgically obtained from the
anesthetized mice. The success of ovariectomy was conﬁrmed by
uterine atrophy in OVX mice.
The bone mineral density of the femurs was assessed using an
X-ray CT System (LA Theata LCT-100; Aloka, Tokyo, Japan). We
monitored the bone mineral density of femurs at 0.3mm intervals
and separately analyzed each trabecular and cortical bone. Values
at 2.1mmand 2.4mm from the epiphysis of the femur are shown in
the ﬁgures. Animal protocols and procedureswere approved by the
Institutional Animal Care and Use Committee of the Toin
University of Yokohama.
2.9. Statistical analysis
Numerical data have been expressed as mean S.D. values of
the results from three to four cultures, and the signiﬁcance of
differences was analyzed by ANOVA (Dunnett’s test). Statistical
signiﬁcance was set at P<0.05. Experiments were repeated
independently in triplicate and the results were qualitatively
identical in every case.
3. Results
3.1. Antioxidant activity of carnosic acid in cells
We ﬁrst examined the effects of carnosic acid on hydrogen
peroxide (H2O2) levels in MC3T3-E1 cells. As shown in Fig. 2,
carnosic acid decreased H2O2 levels by 70% in MC3T3-E1 cells in a
dose-dependent manner.
3.2. Effects of carnosic acid on cultured osteoblasts
We evaluated the effects of carnosic acid on the differentiation
and mineralization of MC3T3-E1 cells. We added carnosic acid to
the culture medium of post-proliferative cells and assayed ALP
activity (a middle-stagemarker of osteoblastic differentiation) and
calcium deposition (a ﬁnal-stage marker of osteoblastic differen-
tiation). Carnosic acid signiﬁcantly decreased the activity of ALP inMC3T3-E1 cells on day 10 (Fig. 3A). Furthermore, as demonstrated
in Fig. 3B, carnosic acid inhibited calcium deposition by MC3T3-
E1 cells on day 12 in a dose-dependent manner. Exposure of
MC3T3-E1 cells to 10mM carnosic acid decreased calcium
deposition by approximately 50% relative to control cultures
treated with the vehicle alone.
3.3. Effects of carnosic acid on formation of multinucleated osteoclasts
Multinucleated osteoclastic cells were formed from mouse
spleen cells. Fig. 4A shows representative results for the detection
of TRAP activity in multinucleated osteoclastic cells treated with
[(Fig._4)TD$FIG]
Fig. 4. Effects of carnosic acid on osteoclast formation. Carnosic acid was added to
cultures at the indicated concentrations. Cultured cells were then stained for TRAP
activity on day 7. Typical results of staining for the detection of TRAP activity (A).
TRAP-positive multinucleated cells (ﬁve or more nuclei) were counted under a
microscope (B). Columns and bars showmeans S.D. values of the results from ﬁve
wells. Data are representative of the results of three separate experiments.
**P<0.01 vs. vehicle.
[(Fig._5)TD$FIG]
Fig. 5. Effects of carnosic acid on mRNA expression of RANKL and M-CSF by real-
time PCR. The RNeasyMini Kit was used to extract RNA from ST2 cells that had been
exposed to carnosic acid for 2 days. The PCR conditions are described in the
Section 2. Data are representative of results from two separate experiments. Data
are average of the results of two separate experiments.
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Formation of TRAP-positive multinucleated osteoclastic cells
was inhibited with the addition of carnosic acid in a dose-
dependent manner (Fig. 4B). Exposure of spleen cells to 10mM
carnosic acid inhibited the formation of multinucleated osteoclas-
tic cells by 75% relative to control cultures treated with the vehicle
alone (Fig. 4B). Real-time PCR also revealed that carnosic acid
treatment of ST2 cells dose-dependently decreased RANKL mRNA
expression (Fig. 5A). In contrast, carnosic acid did not affect M-CSF
mRNA expression in cells (Fig. 5B).
3.4. Effects of carnosic acid on bone loss in OVX mice
We examined the effects of carnosic acid on bone mineral
density using OVX mice. We used a dose of 10mg/kg body weight
because this concentration reported to be effective in vivo in
previous studies [2,11,12]. Compared with the values for the Sham
group (18.81.9 g), the ﬁnal body weights in the OVX group
(20.80.8 g) were signiﬁcantly increased at 28 days post-
operation. There were no differences in body weight between
the OVX group (20.80.8 g) and the OVX-administered carnosicacid group (20.61.5 g) at 28 days after the operation. Ovariecto-
my induced a severe decrease in the bone mineral density of the
trabecular bone of mice (Fig. 6). At 2.1mm and 2.4mm from the
epiphysis of the femur, the bone mineral density in the OVX group
was signiﬁcantly lower than that in the Sham group (65% and 67%,
respectively). However, administration of carnosic acid at 10mg/kg
body weight did not affect the loss of trabecular bone in OVX mice
(Fig. 6). In addition, carnosic acid did not also affect the loss of
cortical bone mineral density in OVX mice (data not shown).
4. Discussion
It is well known that carnosic acid has anti-oxidant properties.
Recent reports have suggested that reactive oxygen species play an
important role in the regulation of cell proliferation, differentia-
tion, and metabolism. In particular, there have been some reports
stating that H2O2 suppressed differentiation markers such as ALP
activity, type I collagen gene expression, and the mineralization of
osteoblastic cells [22–24]. Arai et al. [25] reported that minerali-
zation by MC3T3-E1 cells was reduced to half after a single
exposure to H2O2 within the non-toxic concentration range. By
contrast, it has been reported that continuously generated H2O2
stimulates the proliferation and osteoblastic differentiation of
human periodontal ligament ﬁbroblasts [26]. In this study, we
showed that carnosic acid decreased the level of H2O2 in MC3T3-
E1 cells (Fig. 2) and inhibitedALP activity and deposition of calcium
by MC3T3-E1 cells (Fig. 3). Furthermore, we demonstrated that
carnosic acid inhibited the formation ofmultinucleated osteoclasts
via suppression of RANKL mRNA expression. These ﬁndings
indicate that carnosic acid exhibited inhibitory effects on both
osteoblastogenesis and osteoclastogenesis in vitro. Therefore, to
conﬁrm whether carnosic acid contributes in reducing the risk of
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Fig. 6. Effects of carnosic acid on the bone mineral density of the femurs of OVX
mice. BALB/c female mice (6-weeks old) underwent a sham operation (n =5) or
were surgically ovariectomized (OVX; n =10) under anesthesia. Mice were assigned
to three groups (n =5 for each): sham, sham-operated controls; OVX controls;
OVX+CA, OVX administered intraperitoneallywith CA (10mg/kg bodyweight) at 3-
day intervals. After the 28-day experimental period, the left and right femurs were
surgically collected from anaesthetized mice. Bone mineral density of the femurs
(trabecular bone and cortical bone) was assessed using an X-ray CT System (LA
Theata LCT-100; Aloka). It was monitored at 0.3-mm intervals, and the values at
2.1mmand 2.4mm from the femur epiphysis are shown in the ﬁgures. Columns and
bars show means S.D. values of the results from ﬁve mice.
H. Hagiwara et al. / PharmaNutrition 3 (2015) 1–6 5osteoporosis, we investigated the preventive effects of carnosic
acid on bone formation in vivo. Our results showed that injection of
10mg/kg carnosic acid in OVX mice did not affect bone loss in
trabecular bone. Our previous experiments showed that olive
polyphenol oleuropein and hydroxytyrosol [2] and olive and
parsley polyphenol apigenin [12] prevented trabecular bone loss at
a concentration of 10mg/kg body weight in OVX mice. Experi-
ments involving OVX female Sprague-Dawley rats [27] have also
shown that apigenin prevented trabecular bone loss. Future
studies on high-dose carnosic acid in OVX mice may aid the
prevention of osteoporosis. We also hypothesized from our results
that carnosic acid may decompose in the body. Furthermore, the
inhibitory effects of carnosic acid on the formation of multinucle-
ated osteoclasts might harmonize with inhibition of osteoblastic
differentiation in the body.
In this study, we demonstrated that carnosic acid inhibited the
formation of multinucleated osteoclasts via repression of RANKL
gene expression in ST2 cells. To date, it has been reported that
polyphenols, such as quercetin fromonion [28,29], ﬁsetin [30], and
chlorogenic acid from fructus of Gardenia jasminoides [31]
decreased osteoclastic differentiation induced by the addition of
RANKL in the culture system. In contrast, we showed that carnosic
acid directly inhibited RANKL mRNA expression in ST2 cells.
Quercetin also decreased RANKL gene expression in osteoblasts
[32]. Carnosic acid may be used as an effective remedy in the
treatment of the symptoms of osteoporosis, if we are able to
elucidate the mechanisms by which carnosic acid speciﬁcally
operates upon stromal cells to express RANKL.5. Conclusions
Carnosic acid markedly inhibited the formation of multinucle-
ated osteoclasts in culture via suppression of RANKL mRNA
expression. These ﬁndings provide insights into the development
of tools useful for the prevention and treatment of osteoporosis.
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Carnosic acid is a major polyphenol of rosemary and
possesses potent anti-oxidant effects. In addition to its anti-
oxidant activity, carnosic acid possesses anti-inﬂammatory,
anti-bacterial, anti-cancer properties, and provides protec-
tion to neurons. However, little information is available on
the effects of carnosic acid on bone metabolism with regard
to osteoblast and osteoclast functions. The present study
was designed to evaluate in vitro and in vivo effects of
carnosic acid on bone formation andmaintenance. Carnosic
acid attenuated H2O2 levels in osteoblastic MC3T3-E1 cells.
This compound also inhibited the indices of osteoblast
differentiation, such as alkaline phosphatase activity and
calcium deposition in osteoblastic MC3T3-E1 cells at
concentrations of 3–10mM. Furthermore, it decreased the
formation of multinucleated osteoclasts. In addition, we
identiﬁed a molecular pathway of osteoclast differentiation
mediated by carnosic acid, which led to inhibition of the
expression of receptor activator of nuclear factor-kB ligand
in ST2 cells. Interestingly, intraperitoneal injection of
carnosic acid at 10mg/kg body weight did not signiﬁcantly
affect trabecular bone loss in the femurs of ovariectomized
mice. Our ﬁndings indicate that carnosic acidmaybe used as
an effective remedy in the treatment of the symptoms of
osteoporosis.
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